These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
198 related items for PubMed ID: 10945992
21. Differential effects of the cyclin-dependent kinase inhibitors p27(Kip1), p21(Cip1), and p16(Ink4) on vascular smooth muscle cell proliferation. Tanner FC, Boehm M, Akyürek LM, San H, Yang ZY, Tashiro J, Nabel GJ, Nabel EG. Circulation; 2000 May 02; 101(17):2022-5. PubMed ID: 10790340 [Abstract] [Full Text] [Related]
22. Regulation of cyclin-dependent kinase 4 during adipogenesis involves switching of cyclin D subunits and concurrent binding of p18INK4c and p27Kip1. Phelps DE, Xiong Y. Cell Growth Differ; 1998 Aug 02; 9(8):595-610. PubMed ID: 9716177 [Abstract] [Full Text] [Related]
23. AG490 inhibits G1-S traverse in BALB/c-3T3 cells following either mitogenic stimulation or exogenous expression of E2F-1. Savell J, Ma Y, Morrow KS, Jove R, Olashaw N, Moseley PL, Cress WD, Wharton W. Mol Cancer Ther; 2004 Feb 02; 3(2):205-13. PubMed ID: 14985461 [Abstract] [Full Text] [Related]
24. Trichostatin A inhibits proliferation and induces expression of p21WAF and p27 in human brain tumor cell lines. Wang ZM, Hu J, Zhou D, Xu ZY, Panasci LC, Chen ZP. Ai Zheng; 2002 Oct 02; 21(10):1100-5. PubMed ID: 12508652 [Abstract] [Full Text] [Related]
25. Molecular mechanisms underlying interferon-alpha-induced G0/G1 arrest: CKI-mediated regulation of G1 Cdk-complexes and activation of pocket proteins. Sangfelt O, Erickson S, Castro J, Heiden T, Gustafsson A, Einhorn S, Grandér D. Oncogene; 1999 May 06; 18(18):2798-810. PubMed ID: 10362250 [Abstract] [Full Text] [Related]
26. Deacetylase inhibition in malignant melanomas: impact on cell cycle regulation and survival. Flørenes VA, Skrede M, Jørgensen K, Nesland JM. Melanoma Res; 2004 Jun 06; 14(3):173-81. PubMed ID: 15179185 [Abstract] [Full Text] [Related]
27. The histone-deacetylase inhibitor Trichostatin A blocks proliferation and triggers apoptotic programs in hepatoma cells. Herold C, Ganslmayer M, Ocker M, Hermann M, Geerts A, Hahn EG, Schuppan D. J Hepatol; 2002 Feb 06; 36(2):233-40. PubMed ID: 11830335 [Abstract] [Full Text] [Related]
28. Differential responses of skin cancer-chemopreventive agents silibinin, quercetin, and epigallocatechin 3-gallate on mitogenic signaling and cell cycle regulators in human epidermoid carcinoma A431 cells. Bhatia N, Agarwal C, Agarwal R. Nutr Cancer; 2001 Feb 06; 39(2):292-9. PubMed ID: 11759294 [Abstract] [Full Text] [Related]
30. Regulated ectopic expression of cyclin D1 induces transcriptional activation of the cdk inhibitor p21 gene without altering cell cycle progression. Hiyama H, Iavarone A, LaBaer J, Reeves SA. Oncogene; 1997 May 29; 14(21):2533-42. PubMed ID: 9191053 [Abstract] [Full Text] [Related]
31. The cyclin-dependent kinase inhibitor p27(Kip1) is involved in thyroid hormone-mediated neuronal differentiation. Perez-Juste G, Aranda A. J Biol Chem; 1999 Feb 19; 274(8):5026-31. PubMed ID: 9988748 [Abstract] [Full Text] [Related]
32. The cancer preventive flavonoid silibinin causes hypophosphorylation of Rb/p107 and Rb2/p130 via modulation of cell cycle regulators in human prostate carcinoma DU145 cells. Tyagi A, Agarwal C, Agarwal R. Cell Cycle; 2002 Feb 19; 1(2):137-42. PubMed ID: 12429923 [Abstract] [Full Text] [Related]